$Kodiak Sciences (KOD.US)$ announced first time results of K...

JuliaBiswas commented on a stock · Feb 4 22:11

$Kodiak Sciences(KOD.US)$ announced first time results of KSI-501 ABC Phase 1 study. The data outlined safety and biocativity of KSI-501, along with high binding affinity and bioactivity against VEGF and IL-6.

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

3417 Views

Comment

JuliaBiswas

11Followers

61Following

97Visitors